The results of a small pilot study in humans may suggest that the peroxisome proliferator-activated receptor (PPAR-γ) agonists may preserve or improve cognitive function in AD [174], due to their possible positive effect on insulin signaling in the brain. The gene discussed is INS; the disease is Alzheimer disease.